Plant compound may ward off cancer spread, recurrence
the ONA take:
A compound and enzyme found in cruciferous vegetables such as cauliflower and broccoli may help to prevent the spread and recurrence of some cancers, according to a study out of South Dakota.
Moul Dey, PhD, and her researchers from South Dakota State University have been doing research on phenethyl isothiocyanate (PEITC), a compound and enzyme in these vegetables that combine while chewing.
While PEITC may be developed as an effective dietary supplement, studies demonstrate that cancer-preventing levels of PEITC may be achieved through diet alone.
When Dr. Dey and her colleagues treated cervical cancer stem cells with a 20-micromolar concentration of the PEITC compound in a petri dish, they found that about 75 percent of them diet within 24 hours.
Lower concentrations were also found to be effective. Working with veterinarians, Dey found that 10-micromolar concentrations of PEITC was able to significantly prevent the spread of cancer in mouse lung tissue.
Further testing, she urged, is necessary to determine outcomes in humans.
A compound and enzyme found in cruciferous vegetables may help to prevent the spread and recurrence of some cancers.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Clinical Use of Cabozantinib in the Treatment of Advanced Kidney Cancer: Efficacy, Safety, and Patient Selection
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|